Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CRN017
MIFTS: 47

Coronary Thrombosis

Categories: Cardiovascular diseases, Blood diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Coronary Thrombosis

About this section

MalaCards integrated aliases for Coronary Thrombosis:

Name: Coronary Thrombosis 12 55 44 15 73
Coronary Artery Thrombosis 12

Classifications:

MalaCards categories:
Anatomical: Cardiovascular diseases Blood diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:11847
ICD10 33 I21 I22
MeSH 44 D003328
UMLS 73 C0010072
Sources

Summaries for Coronary Thrombosis

About this section
MalaCards based summary : Coronary Thrombosis, also known as coronary artery thrombosis, is related to heparin-induced thrombocytopenia and protein s deficiency. An important gene associated with Coronary Thrombosis is PLAT (Plasminogen Activator, Tissue Type), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and ECM-receptor interaction. The drugs Aspirin and Everolimus have been mentioned in the context of this disorder. Affiliated tissues include heart, neutrophil and myeloid, and related phenotypes are hematopoietic system and homeostasis/metabolism

Wikipedia : 76 Coronary thrombosis is the formation of a blood clot inside a blood vessel of the heart. This blood clot... more...

Sources

Related Diseases for Coronary Thrombosis

About this section

Diseases related to Coronary Thrombosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 148)
# Related Disease Score Top Affiliating Genes
1 heparin-induced thrombocytopenia 29.8 F3 SERPINC1
2 protein s deficiency 29.4 F3 SERPINC1
3 thrombocytopenic purpura, autoimmune 29.4 GP1BA GP6 ITGB3
4 antiphospholipid syndrome 29.3 F3 PLAT SERPINC1
5 thrombocytopenia 29.1 F3 GP1BA ITGB3
6 thrombocytosis 29.0 F3 SERPINC1
7 endocarditis 29.0 PLAT SERPINC1
8 thrombotic thrombocytopenic purpura 28.8 F3 VWF
9 thrombosis 28.3 F3 GP1BA PLAT SERPINC1 SERPINE1 VWF
10 pulmonary embolism 28.1 F3 PLAT SERPINC1 SERPINE1
11 acute myocardial infarction 28.0 F3 PLAT SERPINC1 SERPINE1 VWF
12 disseminated intravascular coagulation 27.9 F3 PLAT SERPINC1 SERPINE1
13 essential thrombocythemia 27.8 F3 ITGB3 SERPINE1 VWF
14 purpura 27.7 F3 GP1BA ITGB3 SERPINC1 VWF
15 angina pectoris 27.5 F3 SERPINC1 SERPINE1 VWF
16 thrombophilia 27.0 F3 PLAT SERPINC1 SERPINE1 VWF
17 arteries, anomalies of 26.8 F3 P2RY12 PLAT SERPINC1 SERPINE1 VWF
18 vascular disease 26.4 F3 ITGB3 PLAT SERPINC1 SERPINE1 VWF
19 coronary artery anomaly 25.9 F3 GP6 ITGB3 P2RY12 PLAT SERPINE1
20 myocardial infarction 25.4 F3 GP1BA GP6 ITGB3 P2RY12 PLAT
21 coronary restenosis 10.7 PLAT SERPINC1
22 posterior myocardial infarction 10.6 PLAT SERPINC1
23 sudden sensorineural hearing loss 10.6 ITGB3 SERPINC1
24 encephalopathy, familial, with neuroserpin inclusion bodies 10.6 PLAT SERPINC1
25 fetal and neonatal alloimmune thrombocytopenia 10.6 GP1BA ITGB3
26 autosomal dominant macrothrombocytopenia 10.6 GP1BA ITGB3
27 dysfibrinogenemia 10.5 PLAT SERPINC1
28 arteritic anterior ischemic optic neuropathy 10.5 GP1BA ITGB3
29 eisenmenger syndrome 10.5 PLAT VWF
30 clopidogrel resistance 10.4 ITGB3 P2RY12
31 pseudo-von willebrand disease 10.4 GP1BA VWF
32 acquired von willebrand syndrome 10.4 GP1BA VWF
33 plasminogen activator inhibitor-1 deficiency 10.4 PLAT SERPINE1
34 von willebrand disease, type 3 10.4 GP1BA VWF
35 autoimmune disease of blood 10.4 ITGB3 VWF
36 central serous chorioretinopathy 10.4 PLAT SERPINE1
37 acute cor pulmonale 10.3 PLAT SERPINE1
38 acute pulmonary heart disease 10.3 PLAT SERPINE1
39 subendocardial myocardial infarction 10.3 SERPINC1 SERPINE1
40 retinal artery occlusion 10.3 SERPINC1 SERPINE1
41 nonarteritic anterior ischemic optic neuropathy 10.3 GP1BA SERPINC1
42 meningococcemia 10.3 SERPINC1 SERPINE1
43 post-thrombotic syndrome 10.2 SERPINC1 SERPINE1
44 chronic venous insufficiency 10.2 PLAT SERPINE1
45 legg-calve-perthes disease 10.2 SERPINC1 SERPINE1
46 portal vein thrombosis 10.2 SERPINC1 SERPINE1
47 ischemic optic neuropathy 10.2 GP1BA ITGB3 SERPINC1
48 platelet aggregation, spontaneous 10.1 PLAT SERPINC1 VWF
49 epileptic encephalopathy, childhood-onset 10.1 SERPINC1 SERPINE1
50 intestinal impaction 10.1 F3 SERPINC1

Graphical network of the top 20 diseases related to Coronary Thrombosis:



Diseases related to Coronary Thrombosis
Sources

Symptoms & Phenotypes for Coronary Thrombosis

About this section

MGI Mouse Phenotypes related to Coronary Thrombosis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.91 SERPINC1 SERPINE1 F3 VWF GP1BA GP6
2 homeostasis/metabolism MP:0005376 9.81 SERPINC1 SERPINE1 F3 VWF GP1BA GP6
3 cardiovascular system MP:0005385 9.8 SERPINC1 SERPINE1 F3 VWF ITGB3 PLAT
4 immune system MP:0005387 9.5 SERPINC1 SERPINE1 F3 VWF GP6 ITGB3
5 vision/eye MP:0005391 9.02 PLAT SERPINC1 F3 GP6 ITGB3
Sources

Drugs & Therapeutics for Coronary Thrombosis

About this section

Drugs for Coronary Thrombosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 63)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
2
Everolimus Approved Phase 4,Phase 1,Phase 2 159351-69-6 6442177
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 22916-47-8 4189
4
Sirolimus Approved, Investigational Phase 4,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
5
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
6
Tirofiban Approved Phase 4 144494-65-5 60947
7 Platelet Aggregation Inhibitors Phase 4,Phase 3,Phase 2
8 Anti-Infective Agents Phase 4,Phase 1,Phase 2
9 Anti-Bacterial Agents Phase 4,Phase 1,Phase 2
10 Antibiotics, Antitubercular Phase 4,Phase 1,Phase 2
11 Antifungal Agents Phase 4,Phase 1,Phase 2
12 Immunosuppressive Agents Phase 4,Phase 1,Phase 2
13 Anticholesteremic Agents Phase 4
14 Antimetabolites Phase 4
15 Atorvastatin Calcium Phase 4 134523-03-8
16 Calcium, Dietary Phase 4
17 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4
18 Hypolipidemic Agents Phase 4
19 Lipid Regulating Agents Phase 4
20 Analgesics Phase 4,Phase 3
21 Analgesics, Non-Narcotic Phase 4,Phase 3
22 Anti-Asthmatic Agents Phase 4
23 Anti-Inflammatory Agents Phase 4,Phase 3
24 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3
25 Antipyretics Phase 4,Phase 3
26 Antirheumatic Agents Phase 4,Phase 3
27 Autonomic Agents Phase 4
28 Bronchodilator Agents Phase 4
29 Cyclooxygenase Inhibitors Phase 4,Phase 3
30 Fibrinolytic Agents Phase 4,Phase 3
31 Neuroprotective Agents Phase 4
32 Peripheral Nervous System Agents Phase 4,Phase 3
33 Phosphodiesterase 3 Inhibitors Phase 4
34 Phosphodiesterase Inhibitors Phase 4
35 Protective Agents Phase 4
36 Respiratory System Agents Phase 4
37 Vasodilator Agents Phase 4
38 Antacids Phase 4,Phase 3
39 Anti-Ulcer Agents Phase 4,Phase 3
40 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
41 Gastrointestinal Agents Phase 4,Phase 3
42 Proton Pump Inhibitors Phase 4,Phase 3
43
Clopidogrel Approved Phase 3 120202-66-6, 113665-84-2 60606
44
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
45
Ticlopidine Approved Phase 3 55142-85-3 5472
46 Neurotransmitter Agents Phase 3,Phase 2
47 Purinergic P2 Receptor Antagonists Phase 3,Phase 2
48 Purinergic P2Y Receptor Antagonists Phase 3,Phase 2
49 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid Phase 3
50 Lipoxygenase Inhibitors Phase 3

Interventional clinical trials:

(show all 28)
# Name Status NCT ID Phase Drugs
1 Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Unknown status NCT00963781 Phase 4 Reduced duration (6 months) DAPT
2 Safety and Efficacy Study Comparing 3 New Types of Coronary Stents Completed NCT01166685 Phase 4
3 Atorvastatin in Acute Stroke Treatment Completed NCT02225834 Phase 4 Atorvastatin
4 Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients Not yet recruiting NCT02933788 Phase 4 Cilostazol;Acetylsalicylic acid
5 Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation Terminated NCT00445263 Phase 4 TIROFIBAN
6 Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control Withdrawn NCT00713947 Phase 4 during one week for the active treatments;Pantoprazole;Placebo Formula 515
7 Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina Suspended NCT00353067 Phase 3 veliflapon (DG-031)
8 Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) Terminated NCT00557921 Phase 3 CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;Plavix (clopidogrel 75 mg) and aspirin
9 OCT Evaluation of Healing of COMBO Stent Completed NCT01274234 Phase 1, Phase 2
10 A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome Completed NCT00619164 Phase 2 E5555;E5555;E5555;Placebo
11 Maintenance of Platelet Inhibition With Cangrelor Completed NCT00767507 Phase 2 cangrelor
12 Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3 Unknown status NCT02591264
13 Monitoring Response to Antiplatelet Therapy Unknown status NCT00327041
14 Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals Unknown status NCT00973375
15 Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis Completed NCT03180931
16 The SCRIPPS DES REAL WORLD Registry Completed NCT00714623
17 Platelet Acetyl Coenzyme A Carboxylase Phosphorylation in Coronary Artery Disease Completed NCT03034148 Not Applicable
18 Xtract™ Aspiration Catheter Registry Study Completed NCT00349570 Not Applicable
19 The Cholesterol-lowering Efficacy of Probiotic Lactobacillus Plantarum in Hypercholesterolaemic Adults Completed NCT03263104 Not Applicable
20 Assessment of Coagulation and Thrombocyte Function After Termination of Ticagrelor Completed NCT02297971
21 Myeloid-Related Protein in Evaluation of Acute Chest Pain in the Emergency Departement Completed NCT00657436
22 Optical Coherence Tomography in Patients With Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease Completed NCT02783963 Not Applicable
23 The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort Completed NCT03191227
24 Myocardial Injury Following Non-cardiac Surgery Recruiting NCT03317561
25 Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome Recruiting NCT02562690
26 OFDI-Quantified Intracoronary Thrombus, Antiplatelet Pretreatment Effect and Myocardial Reperfusion Recruiting NCT03342521
27 PRE-DETERMINE Cohort Study Active, not recruiting NCT01114269
28 The Efficacy of Cholesterol-lowering Probiotic Lactobacillus Planetarium in Adults With High Cholesterol Not yet recruiting NCT03540108 Not Applicable

Search NIH Clinical Center for Coronary Thrombosis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: coronary thrombosis

Sources

Genetic Tests for Coronary Thrombosis

About this section
Sources

Anatomical Context for Coronary Thrombosis

About this section

MalaCards organs/tissues related to Coronary Thrombosis:

41
Heart, Neutrophil, Myeloid, Lung, Testes, Endothelial, Adrenal Gland
Sources

Publications for Coronary Thrombosis

About this section

Articles related to Coronary Thrombosis:

(show top 50) (show all 525)
# Title Authors Year
1
rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats. ( 29407168 )
2018
2
Serious Coronary Thrombosis and Pulmonary Artery Thrombosis Revealing BehAset's Disease. ( 29900996 )
2018
3
Optical Coherence Tomography for Guiding Plaque Stabilization in a Patient With Myocardial Infarction and Massive Coronary Thrombosis. ( 29958180 )
2018
4
Tissue plasminogen activator for neonatal coronary thrombosis presenting with mitral valve regurgitation and impaired ventricular function. ( 28140523 )
2017
5
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. ( 28867009 )
2017
6
Therapeutic application of contrast ultrasound in ST elevation myocardial infarction: Role in coronary thrombosis and microvascular obstruction. ( 28868906 )
2017
7
A rare cause of acute coronary syndrome: Coronary thrombosis in three coronary arteries due to whey protein. ( 27839839 )
2016
8
Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift? ( 27543999 )
2016
9
Multifocal coronary thrombosis on nondisrupted plaque: observation with optical coherence tomography. ( 27159264 )
2016
10
Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature. ( 26607055 )
2016
11
Early Post-Operative Coronary Thrombosis Following Repair of a Proximal Coronary Artery Fistula. ( 28208917 )
2016
12
Coronary thrombosis in diabetes: Are we doing enough? ( 27555606 )
2016
13
Multiple coronary thrombosis. ( 27489604 )
2016
14
Coronary Thrombosis without Dissection following Blunt Trauma. ( 27006836 )
2016
15
Early Coronary Thrombosis without ST-Segment Elevation Following Repair of Acute Aortic Dissection. ( 28097197 )
2016
16
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. ( 27079334 )
2016
17
Translation from the data of clinical trials to precision medicine: limitation of the current risk score for predicting coronary thrombosis and major bleeding. ( 27746980 )
2016
18
Endothelial erosion of plaques as a substrate for coronary thrombosis. ( 26791872 )
2016
19
Coronary Thrombosis and Type A Aortic Dissection. ( 25980980 )
2015
20
Evading the fate of Pheidippides: acute coronary thrombosis in a young marathon runner with minimal atherosclerosis but sickle cell trait. ( 26331117 )
2015
21
Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment. ( 26761372 )
2015
22
Acute Myocardial Infarction in a Neonate Caused by a Coronary Thrombosis: a Considerable Diagnostic and Therapeutic Challenge. ( 26297178 )
2015
23
Simultaneous multi-vessel coronary thrombosis in patients with ST-elevation myocardial infarction: a systematic review. ( 25772369 )
2015
24
Acute coronary thrombosis and multiple coronary aneurysms in a 22-year-old man with the human immunodeficiency virus. ( 24808786 )
2014
25
Multiple and Contemporary Coronary Thrombosis inspite of Low Platelet Function Response. ( 25302230 )
2014
26
Low-Dose Antithrombotic Treatment in Coronary Thrombosis of Kawasaki Disease. ( 25298222 )
2014
27
Acute ST Elevated Myocardial Injury due to Coronary Thrombosis during Thoracic Endovascular Aortic Repair in Patient with Protein S Deficiency. ( 25469146 )
2014
28
Acute myocardial infarction due to coronary thrombosis caused by blunt chest trauma. ( 24769662 )
2014
29
Coronary thrombosis from large, nonprotruding, superficial calcified coronary plaques. ( 24080108 )
2013
30
Varenicline-induced coronary thrombosis. ( 24259623 )
2013
31
Mechanisms of coronary thrombosis in cigarette smoke exposure. ( 23685556 )
2013
32
Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. ( 23460076 )
2013
33
Detection of coronary thrombosis after multi-phase postmortem CT-angiography. ( 22981180 )
2013
34
Simultaneous double coronary thrombosis in a 47-year-old male patient with acute myocardial infarction. ( 24175009 )
2013
35
Antithrombotic effect of Z4A5 on coronary thrombosis in a canine model of acute unstable angina. ( 23083032 )
2013
36
Bi-ostial coronary thrombosis due to heparin induced thrombocytopenia. ( 22664366 )
2013
37
Acute coronary thrombosis after anaphylactic shock treatment. ( 22541413 )
2012
38
Calcified nodules: an underrated mechanism of coronary thrombosis? ( 23058076 )
2012
39
Coronary thrombosis as the first complication of antiphospholipid syndrome. ( 22735914 )
2012
40
Proteomic profiling of acute coronary thrombosis reveals a local decrease in pigment epithelium-derived factor in acute myocardial infarction. ( 22315956 )
2012
41
Diastolic timed Vibro-Percussion at 50 Hz delivered across a chest wall sized meat barrier enhances clot dissolution and remotely administered Streptokinase effectiveness in an in-vitro model of acute coronary thrombosis. ( 23146079 )
2012
42
Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy. ( 22218740 )
2012
43
Acute coronary thrombosis in Boston marathon runners. ( 22236231 )
2012
44
Cannabis and coronary thrombosis: What is the role of platelets? ( 21806494 )
2012
45
Myocardial infarction due to coronary thrombosis in a patient with Henoch-SchAPnlein purpura. ( 22361720 )
2012
46
Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study. ( 22684577 )
2012
47
Does sildenafil contribute to acute coronary thrombosis? ( 23363902 )
2012
48
Multivessel coronary thrombosis in a patient with idiopathic thrombocytopenic purpura. ( 23304046 )
2012
49
Coronary thrombosis and myocardial infarction as the initial manifestation of protein C deficiency in a 20-year-old man. ( 21481934 )
2011
50
Cocaine-induced coronary thrombosis: what is the optimal treatment strategy. ( 21421194 )
2011
Sources

Variations for Coronary Thrombosis

About this section
Sources

Expression for Coronary Thrombosis

About this section
Search GEO for disease gene expression data for Coronary Thrombosis.
Sources

Pathways for Coronary Thrombosis

About this section

Pathways related to Coronary Thrombosis according to GeneCards Suite gene sharing:

(show all 14)
# Super pathways Score Top Affiliating Genes
1
Response to elevated platelet cytosolic Ca2+ 66
Show member pathways
 12.69 F3 GP1BA GP6 ITGB3 P2RY12 PLAT
2
ECM-receptor interaction 37
Show member pathways
 11.88 GP1BA GP6 ITGB3 VWF
3
Complement and coagulation cascades 1 37
11.8 F3 PLAT SERPINC1 SERPINE1 VWF
4
Adhesion 4
11.78 F3 ITGB3 SERPINE1
5
Platelet activation 37
11.64 GP1BA GP6 ITGB3 P2RY12 VWF
6
Integrin alphaIIb beta3 signaling 66
Show member pathways
 11.62 GP1BA ITGB3 VWF
7
Angiogenesis (CST) 4
11.56 F3 ITGB3 VWF
8
Formation of Fibrin Clot (Clotting Cascade) 66
Show member pathways
 11.37 F3 GP1BA GP6 PLAT SERPINC1 SERPINE1
9
Platelet Aggregation Inhibitor Pathway, Pharmacodynamics 61
11.33 GP6 ITGB3 P2RY12 VWF
10
ECM proteoglycans 66
11.29 ITGB3 SERPINE1
11
amb2 Integrin signaling 1
11.21 GP1BA PLAT
12
Platelet Adhesion to exposed collagen 66
10.66 GP1BA GP6 VWF
13
Dissolution of Fibrin Clot 66
10.61 PLAT SERPINE1
14
GP1b-IX-V activation signalling 66
10.48 GP1BA VWF
Sources

GO Terms for Coronary Thrombosis

About this section

Cellular components related to Coronary Thrombosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.56 F3 GP1BA GP6 ITGB3 PLAT SERPINC1
2 extracellular matrix GO:0031012 9.46 F3 PLAT SERPINE1 VWF
3 cell surface GO:0009986 9.1 F3 GP1BA GP6 ITGB3 P2RY12 PLAT

Biological processes related to Coronary Thrombosis according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 extracellular matrix organization GO:0030198 9.67 ITGB3 SERPINE1 VWF
2 platelet degranulation GO:0002576 9.61 ITGB3 SERPINE1 VWF
3 platelet activation GO:0030168 9.55 GP1BA GP6 ITGB3 P2RY12 VWF
4 platelet aggregation GO:0070527 9.5 GP1BA ITGB3 P2RY12
5 blood coagulation, intrinsic pathway GO:0007597 9.48 GP1BA VWF
6 cell-substrate adhesion GO:0031589 9.46 ITGB3 VWF
7 fibrinolysis GO:0042730 9.43 GP1BA PLAT SERPINE1
8 hemostasis GO:0007599 9.43 F3 GP1BA GP6 P2RY12 SERPINC1 VWF
9 regulation of blood coagulation GO:0030193 9.4 GP1BA SERPINC1
10 smooth muscle cell migration GO:0014909 9.37 ITGB3 PLAT
11 blood coagulation GO:0007596 9.23 F3 GP1BA GP6 ITGB3 P2RY12 PLAT

Molecular functions related to Coronary Thrombosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protease binding GO:0002020 9.02 F3 ITGB3 SERPINC1 SERPINE1 VWF
Sources

Sources for Coronary Thrombosis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....